Results 191 to 200 of about 52,325 (288)
Herpes zoster vaccination and incident dementia in Canada: an analysis of natural experiments. [PDF]
Pomirchy M +4 more
europepmc +1 more source
Vacinas em desenvolvimento: estreptococo do grupo B, herpes-zóster, HIV, malária e dengue [PDF]
Luiz Jacintho da Silva, Rosana Richtmann
openalex +1 more source
Safety of upadacitinib in atopic dermatitis in randomized clinical trials across 6 years
The current study found no evidence of cumulative increased safety risks with upadacitinib 15 or 30 mg for up to 6 years and over 9000 patient‐years of safety data in adults and adolescents. There were low rates of adjudicated major adverse cardiovascular events, adjudicated thromboembolic events and malignancies. Abstract Background Atopic dermatitis (
Christopher G. Bunick +13 more
wiley +1 more source
Review of Herpes Zoster Occurrence in Patients With Atopic Dermatitis Treated With JAK Inhibitors. [PDF]
Mandecka A +7 more
europepmc +1 more source
Clinical Management of Herpes Zoster Complicated by MRSA Infection. [PDF]
Chen X, Yu Q, Chang D, Sun L.
europepmc +1 more source
Epidemiologia de Infecções de VIH positivos no Hospital Santo António [PDF]
Micaela Patrícia Pereira Rodrigues
core
Herpes zóster Simuladores que pueden desviar nuestra atención
Gisela Vaglio Giors +5 more
openalex +2 more sources
ABSTRACT Background Scarring is a common dermatologic concern with both aesthetic and functional implications. Polynucleotide (PN)‐based injectables have emerged as medical devices in dermatologic practice; however, real‐world evidence on their use in scar management remains limited.
Nark Kyoung Rho +3 more
wiley +1 more source
Herpes Zoster Induced by the Shingrix Vaccine: A Case Report and Literature Review. [PDF]
Satow K +3 more
europepmc +1 more source

